European Journal of Molecular & Clinical Medicine

Background: In recent years, Non-communicable diseases (NCDs) have been shown
in developed countries to have an increasingly important impact on their health status
worldwide. The NCDs are the world's leading cause of death and a significant threat
to public health in developing countries. Almost 71 per cent of deaths worldwide are
individually responsible for non-communicable diseases including cardiovascular
diseases, stroke, cancer, diabetes and chronic condition. Almost three-fourths patients
with non-communicable diseases have died before the age of 70 and 82% of 16 million
prematurely deaths are in small and average countries are due to NCDs as per the
WHO report 2018. India is undergoing rapid transitions with increase in Noncommunicable
diseases (NCDs), that are resulting into significant rise in morbidity
and mortality in Urban and rural populations.47% of the patients in India are bearing
the treatment cost (Out of Pocket) themselves. Stem cell therapy is becoming the
crucial line of treatment for these diseases. In fact, from last two decades, Stem cells
derived from cord blood were used for treatment of blood disorders, immune systems
and metabolic diseases as an alternative to bone marrow transplants. In 2016, Noncommunicable
diseases (NCDs) control initiative was implemented by the Indian
government to educate about the use of stem cells to treat non-communicable diseases.
Doctors and biotech companies are helping to educate pregnant women to encourage
the use of stem cells so they can decide to store their child's cord blood as needed for
future use. Henceforth, this paper aims for understanding the attitude of Indian
pregnant women for the storage and usage of stem cell that would be a critical bioinsurance
for baby’s well –being